Science Explorer Back to mapMap
Discussion
Researcher · The University of Texas MD Anderson Cancer Center · United States

Funda Meric‐Bernstam

Funda Meric‐Bernstam publishes mostly in Oncology, Cancer Research and Molecular Biology, on topics such as Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies and HER2/EGFR in Cancer Research.

ORCID 0000-0001-6816-6072 OpenAlex
World rank
#6,569
of 7,710,434 ranked researchers
Rank in United States
#2,268
of 1,627,098
Works
2,681
Citations
102k
Citations per work
38.2
h-index
147
i10-index 701Top 0.1% in Oncology
Funda Meric‐Bernstam

What does Funda Meric‐Bernstam research?

Funda Meric‐Bernstam's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (32%).

Health Sciences: 1,174 works · 43.8% of their workMedicine: 1,174 works · 43.8% of their workOncology: 595 works · 22.2% of their workPulmonary and Respiratory Medicine: 306 works · 11.4% of their workPathology and Forensic Medicine: 147 works · 5.5% of their workSurgery: 126 works · 4.7% of their workLife Sciences: 853 works · 31.8% of their workBiochemistry, Genetics and Molecular Biology: 853 works · 31.8% of their workCancer Research: 472 works · 17.6% of their workMolecular Biology: 381 works · 14.2% of their workEverything else: 654 works · 24.4% of their workTHEIR WORKFundaMeric‐Bernstam2,681works
Life Sciences32%Health Sciences44%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Health Sciences1,17443.8%
    1. Medicine1,17443.8%
    1. Biochemistry, Genetics and Molecular Biology85331.8%
  3. Everything else65424.4%
  1. 1Oncology22% of their works
  2. 2Cancer Research18% of their works
  3. 3Molecular Biology14% of their works
  4. 4Pulmonary and Respiratory Medicine11% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Surgery5% of their works

Research topics

Which keywords describe Funda Meric‐Bernstam's research?

The keywords of their largest research topics: Targeted Therapy, Breast Cancer, Molecular Subtypes, Cancer Genomics, Mutational Signatures, Chemotherapy, Breast Tumours and Gene Expression.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy5652 topics
  2. Breast Cancer4393 topics
  3. Molecular Subtypes4032 topics
  4. Cancer Genomics3921 topic
  5. Mutational Signatures3921 topic
  6. Chemotherapy3162 topics
  7. Breast Tumours2701 topic
  8. Gene Expression2701 topic
  9. HER21831 topic
  10. Trastuzumab1831 topic
  11. ALK Inhibitors1731 topic
  12. EGFR Mutations1731 topic
  13. CDK4/6 Inhibitors1481 topic
  14. Palbociclib1481 topic
  15. Cetuximab1331 topic
  16. KRAS Mutations1331 topic
  17. Signaling1151 topic
  18. mTOR1151 topic
  19. Mammography1081 topic
  20. Ultrasound1081 topic

Where does Funda Meric‐Bernstam work?

Funda Meric‐Bernstam's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.

How many publications and citations does Funda Meric‐Bernstam have?

OpenAlex counts 2,681 works and 102,356 citations for Funda Meric‐Bernstam, an h-index of 147, ranking #6,569 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Funda Meric‐Bernstam. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.